InvestorsHub Logo
Followers 35
Posts 1771
Boards Moderated 0
Alias Born 09/25/2012

Re: BlackDoggie post# 21097

Saturday, 03/24/2018 8:53:52 PM

Saturday, March 24, 2018 8:53:52 PM

Post# of 233240
Exactly right BlackDoggie. But the point is that every other biotech and comapny that I have seen do a r/s are still stuck in a phase 1 or phase 2 studies. That have not even reported phase 2 yet. RXII was one and that was a disaster.

You can't view CYDY in the same light as all other reverse splits because those companies didn't have anything of value. CYDY has just met the primary endpoint of a phase 3 HIV study that is huge. I believe that once a reverse split is done it will give institutions a chance to buy in.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News